SCHEMBL31720924

SCHEMBL31720924

CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PRCP P42785 2/20 0.41
▸ DPP7 Q9UHL4 1/20 0.40
▸ KDM1A O60341 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ MAPK9 P45984 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ KEAP1 Q14145 1/20 0.37
▸ CALCRL Q16602 1/20 0.36
▸ EPHX2 P34913 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ KDM1B Q8NB78 1/20 0.36
▸ REN P00797 3/20 0.36
▸ BACE1 P56817 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531541 1.00 PRCP (0.41) PRCPDPP7KDM1AMEN1KMT2A
SCHEMBL30844292 0.95 KDM1A (0.44) KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL5402328 0.95 KDM1A (0.44) KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL5402299 0.95 KDM1A (0.44) KDM1AMAPK8MAPK9MAPK10MAOB
SCHEMBL30686002 0.93 MAPK8 (0.42) PRCPDPP7KDM1AMEN1KMT2A
SCHEMBL29531712 0.90 PRCP (0.42) PRCPDPP7KDM1AMEN1KMT2A
SCHEMBL29666842 0.90 MAPK8 (0.49) KDM1AMAPK8MAPK9MAPK10KEAP1
SCHEMBL31019315 0.89 PRCP (0.41) PRCPDPP7KDM1AMEN1KMT2A
SCHEMBL30185737 0.89 MAPK8 (0.46) PRCPDPP7MAPK8MAPK9MAPK10
SCHEMBL29496543 0.89 MEN1 (0.44) PRCPDPP7KDM1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339504-A1 CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS NATIONAL CANCER CENTER (JP) 2025-11-06 — — US disclosed
Send feedback